Skip to main content
. 2018 Feb 1;2018(2):CD001269. doi: 10.1002/14651858.CD001269.pub6

ab Forsyth 1967.

Methods From this report, only the first phase of the first trial is of interest to this review, in which administration of whole‐virus, oil adjuvanted influenza vaccine Invirin (GSK) was compared with placebo in a semi‐randomised allocation. The trial was performed November to December 1962.
Participants Medical students (n = 380) at the Queen's University of Belfast, UK
Interventions Trivalent aqueous vaccine (Invirin) one 0.25 mL dose IM containing strains A/Singapore/1/57, A/England/1/61, B/England/939/59. Placebo (phosphate‐buffered saline) was administered as control. Participants born on odd days were given placebo (n = 186); those born on even days received the vaccine (n = 194).
Outcomes Local reactions: pain, erythema, tenderness, bruises. Stratified by means of scores ranging from 0 to 3 depending on their severity. Systemic reactions: coryza, migraine, paroxysmal tachycardia. All assessed at days 0, 1, 3, 7, 21 after inoculation. Data refer to a 3‐day follow‐up.
Notes Safety data only were extracted.
Government funded
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) High risk Alternate
Allocation concealment (selection bias) High risk Not used
Blinding (performance bias and detection bias) 
 All outcomes Unclear risk Unclear
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk Unclear
Summary assessment High risk Unclear